CCA
TXG icon

Column Capital Advisors’s 10x Genomics TXG Stock Holding History

Column Capital Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$109K Hold
2,638
– – 0.02% 207
2023
Q2 		$147K Buy
2,638
+386
+17% +$20.9K 0.02% 168
2023
Q1 		$126K Buy
2,252
+363
+19% +$17K 0.02% 193
2022
Q4 		$68.8K Hold
1,889
– – 0.01% 256
2022
Q3 		$54K Hold
1,889
– – 0.01% 264
2022
Q2 		$85K Buy
1,889
+707
+60% +$36.7K 0.02% 217
2022
Q1 		$90K Buy
1,182
+264
+29% +$23.1K 0.02% 214
2021
Q4 		$137K Buy
+918
New +$141K 0.03% 163

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return